Medicap S.r.l

Medicap S.r.l specializes in biocompatible artificial hair and plant tools designed for medical applications. Their primary focus is on solutions for hair restoration, specifically targeting the treatment of alopecia in both men and women. The company’s main product line includes devices like the Biofibre 4.0 and Medicap High Density 4.0, which are intended to aid in hair regrowth or replacement.

Medicap S.r.l is based in Italy. The company develops its devices in compliance with the European Medical Device Regulation (MDR) 2017/745, ensuring that its products meet EU standards for safety, performance, and regulatory requirements. This includes adherence to the CE marking process (CE 0373) for individual devices.

Medicap S.r.l’s devices are registered in the EUDAMED database, which is the official European Union database for medical devices. This registry tracks information about manufacturers, devices, and their regulatory status within the EU, ensuring transparency and compliance with MDR requirements.

Medicap S.r.l’s devices are classified under three EU risk categories: Class I, Class IIa, and Class IIb. The classification determines the regulatory scrutiny and compliance requirements for each device. For example, Class IIb devices typically involve a higher risk and require stricter evaluation processes, such as clinical data or specialized conformity assessments, compared to Class I devices.